loadpatents
Patent applications and USPTO patent grants for CRAGE MEDICAL CO., LIMITED.The latest application filed is for "gpc3 and asgpr1 double-targeted transgenic immune effector cell and use thereof".
Patent | Date |
---|---|
GPC3 and ASGPR1 double-targeted transgenic immune effector cell and use thereof Grant 11,453,860 - Wang , et al. September 27, 2 | 2022-09-27 |
Binding unit targeting fibroblast activation protein .alpha. and application thereof Grant 11,447,570 - Li , et al. September 20, 2 | 2022-09-20 |
Anti-CD19 humanized antibody and immune effector cell targeting cd 19 Grant 11,427,633 - Wang , et al. August 30, 2 | 2022-08-30 |
Compositions and methods of cellular immunotherapy Grant 11,419,895 - Li , et al. August 23, 2 | 2022-08-23 |
Chimeric antigen receptor-modified immune effector cell carrying PD-L1 blocking agent Grant 11,299,525 - Li , et al. April 12, 2 | 2022-04-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.